Cent Eur J Public Health 2016, 24(2):133-136
Epidemiology of Invasive Pneumococcal Disease in Czech Children under 5 Years of Age after Routine Immunisation
- 1 Second Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 2 Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Background: The introduction of the surveillance of invasive pneumococcal diseases (IPD) in 2007 has helped to monitor changes in serotype occurrence in the Czech population and assess the impact of routine immunisation against IPD on the child population under 5 years of age.
Methods: Observational study of childhood IPD in the Czech Republic based on the state public health surveillance data comparing pre-immunisation (2007-2008) and post-immunisation (2012-2013) periods.
Results: In the child population there was an overall decline in IPD occurrence of 46.6% (95% CI 63.4-21.9) observed during the post-immunisation period. There was even greater decrease of 71.6% (95% CI 50.4-83.8) in vaccinated children. In the post-immunisation period, Prevenar 13 (PCV13) and Synflorix (PCV10) contributed to a vaccine-type IPD reduction of 95.4% (95% CI 67.0-99.4) and 76.9% (95% CI 36.0-91.7), respectively, compared to unimmunised children. The occurrence of 10 serotypes contained in both commercial vaccines also decreased in unvaccinated children by 61.4% (95% CI 14.5-82.6). However, a rise in the risk of non-vaccine and unspecified serotype acquisition by up to 153% was revealed in unimmunised children when comparing post-immunisation and pre-immunisation periods.
Conclusions: The findings suggest a shift in IPD caused either by vaccine or non-vaccine serotypes between immunised and unimmunised populations of children, which could result in increased incidence of IPD caused by non-vaccine serotypes. Therefore, routine immunisation using only one vaccine with broader serotype coverage together with a higher vaccination rate could raise hopes of further decrease in IPD in the child population.
Keywords: invasive pneumococcal disease, pneumococcal conjugate vaccines, vaccine and non-vaccine serotypes
Received: November 4, 2014; Revised: March 24, 2016; Accepted: March 24, 2016; Published: June 1, 2016 Show citation
References
- Motlová J, Beneš Č, Křížová P. Invasive pneumococcal disease in the Czech Republic in 2000-2008. Zpr Epidemiol Mikrobiol. 2009 Jun;18(6):203-9. (In Czech.)
- Motlová J, Beneš Č, Křížová P. Invasive pneumococcal disease in the Czech Republic in 2009. Zpr Epidemiol Mikrobiol. 2010 Mar;19(3):6877. (In Czech.)
- Motlová J, Kozáková J, Křížová P. Invasive pneumococcal disease in the Czech Republic in 2010. Zpr Cent Epidemiol Mikrobiol. 2011 Feb;20(2):64-9. (In Czech.)
- Motlová J, Beneš Č, Kozáková J, Křížová P. Invasive pneumococcal disease in the Czech Republic in 2011. Zpr Cent Epidemiol Mikrobiol. 2012 Feb;21(2):51-8. (In Czech.)
- Kozáková J, Motlová J, Beneš Č, Šebestová H, Křížová P. Invasive pneumococcal disease in the Czech Republic in 2012. Zpr Cent Epidemiol Mikrobiol. 2013 Mar;22(3):97-104. (In Czech.)
- Kozáková J, Šebestová H, Křížová P. Invasive pneumococcal disease in the Czech Republic in 2013. Zpr Cent Epidemiol Mikrobiol. 2014 Mar;23(3):89-97. (In Czech.)
- Domingues CM, Verani JR, Montenegro Renoiner EI, de Cunto Brandileone MC, Flannery B, de Oliveira LH, et al.; Brazilian Pneumococcal Conjugate Vaccine Effectiveness Study Group. Effectiveness of tenvalent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study. Lancet Respir Med. 2014 Jun;2(6):464-71.
Go to original source...
Go to PubMed...
- Ben-Shimol S, Greenberg D, Givon-Lavi N, Schlesinger Y, Somekh E, Aviner S, et al. Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance. Vaccine. 2014 Jun 5;32(27):3452-9.
Go to original source...
Go to PubMed...
- Levy C, Varon E, Picard C, Béchet S, Martinot A, Bonacorsi S, et al. Trends of pneumococcal meningitis in children after introduction of the 13-valent pneumococcal conjugate vaccine in France. Pediatr Infect Dis J. 2014 Dec;33(12):1216-21.
Go to original source...
Go to PubMed...
- SteensA, Bergsaker MA,Aaberge IS, Rønning K, Vestrheim DF. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine. 2013 Dec 16;31(52):6232-8.
Go to original source...
Go to PubMed...
- Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MP, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015 May;15(5):535-43.
Go to original source...
Go to PubMed...
- Choi YH, Jit M, Gay N, Andrews N, Waight PA, Melegaro A, et al. 7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement? PLoS One. 2011;6(10):e26190. doi: 10.1371/journal.pone.0026190.
Go to original source...
Go to PubMed...
- Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis. 2011 Oct;11(10):760-8.
Go to original source...
Go to PubMed...